McKesson Purchase of Per-Se Gets Antitrust OK
by Mike Bevel, CollectionIndustry.com
Before Per-Se Technologies and McKesson Corporation could pop the champagne and toast their glowing success – McKesson will acquire Per-Se Technologies, Inc. for the low, low price of $1.8 billion — there was a little matter of U.S. anti-trust authorities giving their blessing, too.
And they did. Tuesday, anti-trust authorities approved drug wholesaler McKesson Corp.'s proposed purchase of health administration company Per-Se Technologies.
The purchase broadens McKesson's portfolio of health care software. Per-Se sells software and services to hospitals, physicians and pharmacies.
The acquisition is expected to close in the first quarter of 2007.
Be the First To Comment
(Please read our comments policy first.)
Tell us what topics you're interested in and we'll keep you posted. Enter your email address below.
Topics:
Related Resources
News
Analysis
Publications
Research
